Adamas Pharmaceuticals Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Adamas Pharmaceuticals

Access the complete profile.

Adamas Pharmaceuticals Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	N/AExact Company Size
Primary Industry	3255 Paint, Coating & Adhesive Manufacturing
Address	1900 Powell Street Suite 1000 Emeryville, CA 94608

Adamas Pharmaceuticals's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Adamas Pharmaceuticals's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Adamas Pharmaceuticals is classified as operating in the Paint, Coating & Adhesive Manufacturing industry, NAICS Code 3255.

Adamas Pharmaceuticals is a publicly traded company on NGM using the ticker symbol ADMS. Detailed information on company financials and operating reports can be found here: NGM: ADMS

Adamas Pharmaceuticals Annual Revenue and Growth Rate

Adamas Pharmaceuticals	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$10 - $100 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Adamas Pharmaceuticals's revenues are gauged from an analysis of company filings.

Trademark Applications

Trademark applications show the products and services that Adamas Pharmaceuticals is developing and marketing. Adamas Pharmaceuticals doesn't have any recent trademark applications, indicating Adamas Pharmaceuticals is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
ACCESS OSMOLEX Providing computerized solution-based technologies for the purpose of patient support services to assist patients in accessing medicine; online non-downloadable software for accessing an online searchable database in the field of medical research, drug delivery technology, immediate release and controlled release drugs, and drug interactions; online non-downloadable software in which users can create a profile and input drugs to review drug interactions	07/31/2018
OSMOLEX ER Oral pharmaceuticals for treatment of neurological conditions	10/10/2017
KOBILTI Pharmaceuticals for the treatment of nervous system disorders	07/20/2015

See all trademarks and details in the Full Report.

Market Share of Adamas Pharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as Adamas Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
RPM INTERNATIONAL	Medina, OH	100
AXALTA COATING SYSTEMS	Philadelphia, PA	42
FALLS OF NEUSE MANAGMENT LLC A NORTH CAROLINA	Raleigh, NC	26
NIPPON PAINT USA	Commerce, CA	25
H.B. FULLER	Saint Paul, MN	24
MORGAN ADHESIVES	Stow, OH	19
BENJAMIN MOORE	Montvale, NJ	18
COADAP	Gainesville, TX	13
K-M INDUSTRIES HOLDING	San Carlos, CA	11

Nearby Competitors

These companies are similar in business line and location to Adamas Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
CLOROX	Oakland, CA	100
AMYRIS	Emeryville, CA	21
SANTEN HOLDINGS US	Emeryville, CA	6
SOUND AGRICULTURE	Emeryville, CA	4
GRITSTONE BIO	Emeryville, CA	3
ADAMAS PHARMACEUTICALS	Emeryville, CA	1
DRIP DROP HYDRATION	Emeryville, CA	1
NOVABAY PHARMACEUTICALS	Emeryville, CA	0
XOMA	Emeryville, CA	0
VIBRANT CARE PHARMACY	Oakland, CA	0

Future Competition: Adamas Pharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as Adamas Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)